Company

Coave Therapeutics

Biotechnology Research Paris, Fr 45 employees

Employees: 45
Contacts: 4
Emails: 4
Phones: 1

horama.fr LinkedIn Crunchbase

Coave Therapeutics Overview

Headquarters: Paris, Fr
Website: horama.fr
Industry: Biotechnology Research
Employees: 45
Founded: 2014
Funding: 32.9M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

médecine thérapie génique ophtalmologie Gene Therapy Rare Ocular disease CNS disease

About Coave Therapeutics

Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success will provide rapid validation of our ALIGATER platform.

Coave Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

Coave Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Emmanuelle Coutanceau	Partner at Novo Holdings	Copenhagen, Capital Region of Denmark, Denmark	Email
Fred Chereau	SVP, Strategy and Business Development	Boston, Massachusetts, United States	Email
Alexandre Simon	Head of Intellectual Property	Paris, ÎLe-de-france, France	Email
Aravind Asokan	Professor@duke University - Biotech	Chapel Hill, North Carolina, United States	Email Phone